Medivir AB (MVIRb.ST)
18 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|56||2016||Independent Chairman of the Board|
|43||2017||President, Chief Executive Officer|
|2018||Chief Financial Officer|
|52||Executive Vice President Strategic Regulatory Affairs and Market Access|
|42||2016||Chief Information Officer|
- BRIEF-Medivir Q1 operating loss narrows
- BRIEF-Medivir says new preclinical data on MIV 818 will be presented at the AACR Annual Meeting in April
- BRIEF-Medivir Q4 sales sharply lower, EBITDA loss at 93 mln SEK
- BRIEF-Medivir completes directed issue of around 155 mln SEK
- BRIEF-Medivir Intends To Make A Directed Share Issue